English हिन्दी
Connect with us

Health

What is Pfizer’s Paxloid? Here’s to know everything about Covid-19 pill

Paxloid is an antidrug pill that was issued for the prevention of Covid-19. It is basically a combination of two medications. Here’s to know everything about it.

Published

on

antidrug pill

Covid-19 and its highly contagious variant Omicron cases are increasing rapidly day by day. Also, the hospitalization rates have already reached high. In fact, there are no signs of slowing down so far. Keeping this pandemic situation in mind, the Food and Drug Administration has issued emergency authorization use of Pfizer’s Paxlovid in late December 2021. It is a Covid-19 pill.

Let’s reveal some of the important points about the Covid-19 pill.

What is Pfizer’s Paxloid?

Paxloid is an antidrug pill that was issued for the prevention of Covid-19. It is basically a combination of two medications. The names of the two medications are nirmatrelvir and ritonavir. It is an oral pill that is recommended to take twice a day by health experts.

What does expert say about this Covid-19 pill?

According to the Chief of the Division of Infectious Diseases in the Department of Medicine at the Weill Cornell Medical College and New York-Presbyterian Hospital, Dr Roy M Gullick, the Pfizer pill is that oral antiviral drug that targets an enzyme that is essential for sars-cov-2 to reproduce in the body. Besides this, he mentioned that both Nirmatrelvir and ritonavir bind to that enzyme in the body. It is known as protease. It further prevents it from working. As a result, sars-cov-2 does not reproduce itself inside our bodies.

When you should take the Covid-19 pill?

According to the health experts, as soon as you have been tested positive for Covid-19, this antidrug pill needs to be started as soon as possible. It should be consumed within five days of symptom onset in your body.

What is the future of this pill?

Health experts are expecting to speed up the production of Pfizer’s Paxloid so that more and more doses will be available to the Covid-19 patients.

Is there any other medicinal drug for Covid-19?

Yes, there is also one other medicine that was developed by other companies. A monoclonal antibody was developed by Sotrovimab. It binds to sars-Cov-2 and is given as a single intravenous infusion to the patient.

Health

Covid-19: Delhi reports 2,202 cases, highest in six months; India logs over 20k cases

The fatality rate was recorded at 1.19 percent, and the recovery rate stood at 98.50 percent.

Published

on

Covid-19

The coronavirus has started to raise its ugly head in the country once again. There is currently concern about the fourth wave in India, where the number of Covid-19 cases has been increasing continuously for more than a week.

India reported 20,551 new Covid-19 infections and 70 fatalities in the last 24 hours. According to the Union Ministry of Health and Family Affairs, the daily positivity rate in the country reached 5.14 percent and the weekly positivity rate stood at 4.64 percent. The fatality rate was recorded at 1.19 percent, and the recovery rate stood at 98.50 percent.

India’s tally of Covid-19 cases has risen to 4,41,07,588 and the death toll has climbed to 5,26,600. The active Covid-19 cases in the country stood at 1,35,364.

Read Also: AAP government will open 700 liquor shops in Delhi

The capital registered 2,202 cases, which is the highest in six months. The health department data shows the positivity rate in the capital reached 11.84 percent. On Wednesday, Delhi reported 2,073 Covid-19 cases with a positivity rate of 11.64 percent. The active cases in Delhi are 6,175.

Maharashtra reported 1,862 cases and seven deaths. Assam logged 431 new cases and two fatalities and Odisha recorded 836 new cases. The five states with the most active cases are Kerala, Maharashtra, Karnataka, Tamil Nadu, and Punjab.

In response to the rising number of Covid cases and low booster dose uptake throughout India, the Union Health Ministry has offered free booster doses to all eligible individuals over the age of 18 at government-run vaccination centers.

The nationwide COVID-19 vaccination drive was started in the country on 16 January 2021, since then 2,055,947,243 vaccine doses have been administered across India.

Congress plans to gherao PM residence, Delhi Police denies permission

Bihar: At least 8 dead, several ill after consuming spurious liquor in Saran district


Continue Reading

Delhi news

Delhi reports 3rd monkeypox case, 8th in India

The reports state that the man doesn’t have any foreign travel history.

Published

on

monkeypox

A 31-year-old Nigerian man living in Delhi has been tested positive for monkeypox on Tuesday. According to the reports, the man has been admitted to the Lok Nayak Hospital in Delhi after experiencing symptoms. With this, the capital reported its third monkeypox case, while the total tally has now reached eight.

The Union Ministry of Health and Family Affairs confirmed that the patient does not have any foreign travel history. Union Health Minister Mansukh Mandaviya confirmed that India has a total of eight monkeypox cases and out of which five patients have a history of foreign travel.

Earlier on Sunday, a 35-year-old Nigerian man also tested positive for monkeypox. The patient was admitted to Lok Nayak hospital soon after and his samples have been sent to the National Institute of Virology, Pune for testing.

Read Also: Monkeypox: Amid rise in cases, 21-day isolation, screening at airports, railway stations and bus stands in Bengaluru

The first monkeypox case in Delhi was reported in a 34-year-old man from Paschim Vihar. The patient is currently undergoing treatment. According to the reports, his condition is stable, and he has no symptoms other than lesions.

Earlier in the day, Kerala reported the fifth case of viral infection in a 30-year-old man. The patient is currently admitted to the Manjeri Medical College in Malappuram. The reports state that the patient returned from UAE on July 27.

On Saturday, India reported the first monkeypox fatality. The deceased was a 22-year-old man from Kerala who tested positive for the virus following his return from the United Arab Emirates.

Meanwhile, Karnataka’s capital Bengaluru on Tuesday ordered screening at airports, railway stations and bus stands amid rising monkeypox cases in India.

Jammu and Kashmir: Grenade blast occurs in Ramban district, investigation underway

Trinamool Congress MP Kakoli Ghosh bites raw brinjal in Parliament

Continue Reading

Health

Monkeypox: Amid rise in cases, 21-day isolation, screening at airports, railway stations and bus stands in Bengaluru

According to the revised guidelines, at least 21-day isolation will be mandatory for confirm Monkeypox cases.

Published

on

Monkeypox: Amid rise in cases, 21-day isolation, screening at airports, railway stations and bus stands in Bengaluru

Karnataka’s capital Bengaluru on Tuesday has ordered screening at airports, railway stations and bus stands amid rise in Monkeypox cases in India.

This change has come after the Department of Health and Family Welfare have issued revised guidelines. It also states that at least 21-day isolation will be mandatory for confirm Monkeypox cases.

Moreover, the zonal health officials have also been instructed to ensure that the screening teams are surely be deployed at airports, railway stations and bus stands in their respective jurisdictions. 

“All suspected Monkeypox cases in the community should be tested and screened through both targeted surveillance and hospital-based surveillance,” the guidelines stated.

Heavy rain in Kerala claims six lives, IMD issues red alert in 7 districts

CWG 2022: Weightlifter Harjinder Kaur bags bronze medal in women’s 71kg final, taking the medal tally to 7 in weightlifting

Continue Reading

Trending

-->

© Copyright 2022 APNLIVE.com